Price Alert

Palvella Therapeutics Inc... (PVLA)

NASDAQ: PVLA · Real-Time Price · USD

47.12

1.02 (2.21%)

At close: Aug 15, 2025, 3:59 PM

48.00

1.88%

After-hours: Aug 15, 2025, 05:20 PM EDT

Palvella Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q2 2025	Q1 2025	Q1 2024	Q4 2023	Q3 2023	Q1 2023
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Mar 31, 2023
Net Income	-25.84M	-15.3M	-24.58M	-22.05M	-17.46M	-6.71M
Depreciation & Amortization	n/a	n/a	739K	739K	739K	n/a
Stock-Based Compensation	3.62M	1.24M	287K	141K	141K	141K
Other Working Capital	-2.45M	-16.45M	-30.07M	-30.41M	-16.07M	-550K
Other Non-Cash Items	4.22M	1.41M	18.59M	17.73M	18.47M	2.66M
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-967K	-14.88M	-29.48M	-29.9M	-15.57M	-47K
Operating Cash Flow	-18.97M	-27.54M	-34.45M	-33.35M	-13.68M	-3.95M
Capital Expenditures	n/a	13K	-56K	-56K	-69K	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	-7.57M	-14.59M	-14.59M	-7.03M	n/a
Sales Maturities Of Investments	n/a	11M	16.11M	16.11M	5.11M	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	3.45M	1.47M	1.47M	-1.98M	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-2.12M	-1.27M	n/a	n/a	n/a	n/a
Financial Cash Flow	-2.06M	-1.19M	14K	14K	n/a	n/a
Net Cash Flow	55.11M	-24.58M	-32.6M	-31.5M	-16M	-3.95M
Free Cash Flow	-18.97M	-27.53M	-34.5M	-33.4M	-13.75M	-3.95M